Sign In
Buy DXCM
$82.66
-4.28 (-4.92%)
At Close: Aug 05, 2026
4 Best Stocks Exhibiting Solid Earnings Growth
08:16am, Friday, 17'th Nov 2023
Invest in stocks such as DexCom (DXCM), Arthur J. Gallagher (AJG), Limbach (LMB) and Hartford Financial Services (HIG) for superb earnings growth.
DexCom CF0: GLP-1s and continuous glucose monitoring are companion therapies
02:30pm, Tuesday, 14'th Nov 2023
Jereme Sylvain, CFO at DexCom joins Bloomberg Radio to discuss DexCom's earnings and financial outlook. -------- Get more on The Tape Podcast On Apple: http://bit.ly/3YrBfOi On Spotify: http://bit.ly/
3 Earnings Winners Poised to Outperform the Market
05:35pm, Thursday, 09'th Nov 2023
Sound financial performance indicates that a company may be a good investment choice. The earnings season provides investors another window of opportunity to see which reporting companies exceeded exp
2 Medical Device Companies Experiencing Strong Demand Even as Weight-Loss Drugs Rise in Popularity
09:37am, Wednesday, 08'th Nov 2023
The rise of weight-loss treatments has some investors worried about demand for certain medical devices. Yet, DexCom and Abbott Labs still see strong sales for their continuous glucose monitoring devic
3 Healthcare Stocks Getting Help From the Aging Population
12:25pm, Monday, 06'th Nov 2023
A record number of Americans are now turning 65, Forbes recently reported, amid tens of millions of Baby Boomers. In fact, according to one report, 76.4 million Baby Boomers are living in America curr
2 Growth Stocks That Could Help Set You Up for Life
09:57am, Thursday, 02'nd Nov 2023
Healthcare and e-commerce are two massive, lucrative industries that aren't slowing down. DexCom is riding on a wave of profits and cash from its latest launches.
3 Reasons Growth Investors Will Love DexCom (DXCM)
02:18pm, Tuesday, 31'st Oct 2023
DexCom (DXCM) is well positioned to outperform the market, as it exhibits above-average growth in financials.
What Makes DexCom (DXCM) a New Buy Stock
01:31pm, Tuesday, 31'st Oct 2023
DexCom (DXCM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Dexcom stock climbs as worries surrounding weight-loss drugs fades
10:04pm, Friday, 27'th Oct 2023
CNBC's Angelica Peebles joins 'Closing Bell Overtime' to take a closer look at stock movers in the healthcare sector.
Dexcom Stock Soars on Earnings. Ozempic Isn't the Threat It Was Supposed to Be
02:52pm, Friday, 27'th Oct 2023
The maker of continuous glucose monitoring devices said there was no sign weight-loss drugs were hurting demand for its products.
DexCom (DXCM) Beats on Q3 Earnings, Raises Sales Outlook
09:02am, Friday, 27'th Oct 2023
DexCom's (DXCM) third-quarter 2023 results reflect strong domestic and international revenue growth on the back of its real-time Continuous Glucose Monitoring system.
Dexcom, Inc. (DXCM) Q3 2023 Earnings Call Transcript
07:57pm, Thursday, 26'th Oct 2023
Dexcom, Inc. (NASDAQ:DXCM ) Q3 2023 Earnings Conference Call October 26, 2023 4:30 PM ET Company Participants Sean Christensen - Director, Corporate Affairs & Head of IR Kevin Sayer - Executive Chairm
DexCom (DXCM) Reports Q3 Earnings: What Key Metrics Have to Say
07:35pm, Thursday, 26'th Oct 2023
The headline numbers for DexCom (DXCM) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estim
DexCom (DXCM) Q3 Earnings and Revenues Surpass Estimates
06:48pm, Thursday, 26'th Oct 2023
DexCom (DXCM) came out with quarterly earnings of $0.50 per share, beating the Zacks Consensus Estimate of $0.34 per share. This compares to earnings of $0.28 per share a year ago.
Dexcom Shrugs Off Pressure From Weight-Loss Drugs, Boosts 2023 Outlook. Stock Pops 14%.
04:50pm, Thursday, 26'th Oct 2023
Dexcom topped third-quarter expectations Thursday, shrugging off concerns new weight-loss drugs would undercut its sales. DXCM stock popped.
